FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Compounding Pharmacy Guilty Plea After Product Contamination

[ Price : $8.95]

Main Street Family Pharmacy (Newbern, TN) and co-owner David A. Newbaker plead guilty in Western Tennessee District Court to one m...

Atossa Genetics Resolves Inspection Deficiencies

[ Price : $8.95]

Atossa Genetics says it has received inspection close-out notifications for FDA inspections conducted in 2012 and 2014.

Brookings Drafts Roadmap for Device UDI Implementation

[ Price : $8.95]

A Brookings Institution report says FDA and the Centers for Medicare and Medicaid Services should run a health sector-wide pilot p...

Senators Introduce Bill to Curb FDA Oversight of Mobile Apps

[ Price : $8.95]

Senators Michael Bennet (D-CO) and Orrin Hatch (R-UT) introduce a bill to reduce red tape at FDA and boost innovation in health in...

Courts May Need to Help Generics Get Testing Samples: Lawyers

[ Price : $8.95]

A Wiley Rein client alert opines on a recent draft guidance offering generic drug sponsors one means to get testing samples from r...

Guidance on Safety of BE Study Protocols

[ Price : $8.95]

Federal Register Notice: FDA releases a draft guidance: entitled How to Obtain a Letter from FDA Stating that Bioequivalence Study...

FDA Withdraws 23 NDAs, 68 ANDAs

[ Price : $8.95]

Federal Register Notice: FDA withdraws approval of 23 NDAs and 68 ANDAs that are no longer marketed.

Tentative Approval for Mylan NDAs for HIV Therapies

[ Price : $8.95]

FDA tentatively approves two Mylan NDAs for two dosages of abacavir/lamivudine tablets for oral suspension for treating HIV-1 infe...

Heart Sync Device Correction on Defibrillator Electrodes

[ Price : $8.95]

Heart Sync begins a device correction for certain multi-function defibrillation electrodes due to connector compatibility issue wi...

Guidance for Companies Seeking REMS-protected Testing Samples

[ Price : $8.95]

FDA posts a draft guidance intended to help generic drug sponsors get testing samples from reference-listed drug makers that have ...